Induction treatment with mycophenolate mofetil, cyclosporine, and low-dose steroids with subsequent early withdrawal in renal transplant patients: results of the Spanish group

By Puig i Mar J.M.  

Transplantation Proceedings, Vol. 31, Iss. 6, 1999-09 ,pp. : 2256-2258

Elsevier

Access to resources Recommend Favorite

Neoral dose monitoring with cyclosporine 2-hour postdose levels in heart transplant patients receiving anti-thymocyte globulin induction

By Cantarovich M.   Quantz M.   Elstein E.   Ergina P.   Magnan C.   de Varennes B.  

Transplantation Proceedings, Vol. 32, Iss. 2, 2000-03 ,pp. : 446-448

Elsevier

Access to resources Recommend Favorite

Neoral dose monitoring with cyclosporine 2-hour postdose levels (C 2 ) in different renal transplant patient age groups

By Rosati A.   Bertoni E.   Zanazzi M.   Di Maria L.   Ciuti R.   Piperno R.   Moscarelli L.   Biagini M.   Salvadori M.  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3106-3107

Elsevier

Access to resources Recommend Favorite

Cyclosporine therapeutic drug monitoring

By Jensen S.A.   Dalhoff K.P.  

Transplantation Proceedings, Vol. 33, Iss. 6, 2001-09 ,pp. : 3003-3005

Elsevier

Access to resources Recommend Favorite

Comparison of Cyclosporine Monitoring With Trough Levels to Levels Obtained 6 Hours After the Morning Dose in Heart Transplant Patients: A Prospective Randomized Study

By Cantarovich M.   Latter D.   Fitchett D.  

Transplantation Proceedings, Vol. 29, Iss. 1, 1997-02 ,pp. : 602-604

Elsevier

Access to resources Recommend Favorite